Insider Transactions in Q2 2014 at Cvs Health Corp (CVS)
Insider Transaction List (Q2 2014)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 12
2014
|
Larry J Merlo Director |
SELL
Bona fide gift
|
Direct |
10,000
-8.54%
|
$760,000
$76.82 P/Share
|
|
May 08
2014
|
David W Dorman Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,756
+6.13%
|
$281,700
$75.86 P/Share
|
|
May 08
2014
|
Jean Pierre Millon Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,384
+50.0%
|
$103,800
$75.86 P/Share
|
|
May 08
2014
|
Tony L White Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,384
+7.91%
|
$103,800
$75.86 P/Share
|
|
May 08
2014
|
Nancy Ann Deparle Director |
BUY
Grant, award, or other acquisition
|
Direct |
692
+25.54%
|
$51,900
$75.86 P/Share
|
|
Apr 02
2014
|
Eva C Boratto EVP & CFO |
SELL
Open market or private sale
|
Direct |
17,108
-24.21%
|
$1,265,992
$74.51 P/Share
|
|
Apr 02
2014
|
Eva C Boratto EVP & CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
17,108
+19.44%
|
$752,752
$44.85 P/Share
|
|
Apr 02
2014
|
Andrew Sussman EVP, Clinical Services |
SELL
Open market or private sale
|
Direct |
19,210
-56.22%
|
$1,421,540
$74.02 P/Share
|
|
Apr 02
2014
|
Andrew Sussman EVP, Clinical Services |
BUY
Exercise of conversion of derivative security
|
Direct |
19,210
+35.73%
|
$941,290
$49.8 P/Share
|
|
Apr 01
2014
|
Helena Foulkes EVP & President-CVS Pharmacy |
BUY
Grant, award, or other acquisition
|
Direct |
8,412
+17.71%
|
$622,488
$74.29 P/Share
|
|
Apr 01
2014
|
Thomas M Moriarty EVP & General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
10,095
+31.89%
|
$747,030
$74.29 P/Share
|
|
Apr 01
2014
|
Troyen A Brennan EVP and Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
8,749
+14.89%
|
$647,426
$74.29 P/Share
|
|
Apr 01
2014
|
Troyen A Brennan EVP and Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
7,166
-14.8%
|
$530,284
$74.29 P/Share
|
|
Apr 01
2014
|
J. David Joyner President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
4,038
+14.58%
|
$298,812
$74.29 P/Share
|
|
Apr 01
2014
|
J. David Joyner President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
9,203
-16.85%
|
$681,022
$74.29 P/Share
|
|
Apr 01
2014
|
David M Denton EVP and CFO |
BUY
Grant, award, or other acquisition
|
Direct |
110,095
+23.25%
|
$8,147,030
$74.29 P/Share
|
|
Apr 01
2014
|
David M Denton EVP and CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
6,857
-7.31%
|
$507,418
$74.29 P/Share
|
|
Apr 01
2014
|
Stephen J Gold EVP & CIO |
BUY
Grant, award, or other acquisition
|
Direct |
25,575
+35.61%
|
$1,892,550
$74.29 P/Share
|
|
Apr 01
2014
|
Eva C Boratto EVP & CFO |
BUY
Grant, award, or other acquisition
|
Direct |
3,028
+11.85%
|
$224,072
$74.29 P/Share
|
|
Apr 01
2014
|
Andrew Sussman EVP, Clinical Services |
BUY
Grant, award, or other acquisition
|
Direct |
4,711
+16.81%
|
$348,614
$74.29 P/Share
|
|
Apr 01
2014
|
Larry J Merlo Director |
BUY
Grant, award, or other acquisition
|
Direct |
53,843
+16.98%
|
$3,984,382
$74.29 P/Share
|
|
Apr 01
2014
|
Jonathan C Roberts EVP & Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
11,778
+16.09%
|
$871,572
$74.29 P/Share
|
|
Apr 01
2014
|
Jonathan C Roberts EVP & Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,026
-6.04%
|
$149,924
$74.29 P/Share
|
|
Apr 01
2014
|
Lisa Bisaccia Former EVP & Chief HR Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,384
+16.09%
|
$398,416
$74.29 P/Share
|
|
Apr 01
2014
|
Lisa Bisaccia Former EVP & Chief HR Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,086
-11.74%
|
$228,364
$74.29 P/Share
|